Is MEDRX or NOBL a better dividend investment in 2026?

MEDRX currently yields 6.41% with a 5% 5-year dividend growth rate. NOBL yields 4.00% with 5% growth. The better choice depends on your goal: MEDRX offers higher current income.

What is the dividend yield difference between MEDRX and NOBL?

MEDRX has a forward dividend yield of 6.41% ($2.00/share annually). NOBL yields 4.00% ($2.00/share annually). The yield gap is 2.41 percentage points.

Home › Compare › MEDRX vs NOBL

MEDRX vs NOBL: Dividend Comparison 2026

MEDRX yields 6.41% · NOBL yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MEDRX wins by $2.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

MEDRX

● Live price

6.41%

Share price

$31.22

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.5K

Annual income

$963.09

Full MEDRX calculator →

NOBL

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full NOBL calculator →

Portfolio growth — MEDRX vs NOBL

📍 MEDRX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MEDRX	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MEDRX + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MEDRX pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDRX

Annual income on $10K today (after 15% tax)

$544.52/yr

After 10yr DRIP, annual income (after tax)

$818.63/yr

NOBL

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, MEDRX beats the other by $54.31/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDRX + NOBL for your $10,000?

MEDRX: 50%NOBL: 50%

100% NOBL50/50100% MEDRX

Portfolio after 10yr

$29.3K

Annual income

$931.15/yr

Blended yield

3.18%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDRX buys

NOBL buys

No recent congressional trades found for MEDRX or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMEDRXNOBL

Forward yield	6.41% ✓	4.00%
Annual dividend / share	$2.00	$2.00
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$30.5K ✓	$28.0K
Annual income after 10y	$963.09 ✓	$899.19
Total dividends collected	$8.1K ✓	$6.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: MEDRX vs NOBL ($10,000, DRIP)

Year	MEDRX Portfolio	MEDRX Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$11,341	$640.61	$11,120	$420.00	+$221.00 → MEDRX
2	$12,813	$678.97	$12,357	$458.31	+$456.00 → MEDRX
3	$14,427	$716.96	$13,721	$499.76	+$706.00 → MEDRX
4	$16,192	$754.45	$15,227	$544.58	+$965.00 → MEDRX
5	$18,116	$791.32	$16,885	$593.02	+$1.2K → MEDRX
6	$20,212	$827.47	$18,713	$645.34	+$1.5K → MEDRX
7	$22,490	$862.79	$20,724	$701.81	+$1.8K → MEDRX
8	$24,961	$897.21	$22,938	$762.73	+$2.0K → MEDRX
9	$27,639	$930.66	$25,372	$828.41	+$2.3K → MEDRX
10	$30,537	$963.09	$28,047	$899.19	+$2.5K → MEDRX

MEDRX vs NOBL: Complete Analysis 2026

MEDRX — Stock

The fund is a non-diversified fund that invests all of its investable assets in the Medical Portfolio, a series of Kinetics Portfolios Trust. The Portfolio invests at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants, and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries, with an emphasis toward companies engaged in cancer research and drug development. It is non-diversified.

Full MEDRX Calculator →

NOBL — ETF

NOBL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NOBL shares.

Full NOBL Calculator →

📬

Get this MEDRX vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDRX vs SCHD MEDRX vs JEPI MEDRX vs O MEDRX vs KO MEDRX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.